3. EFFICIENCY OF REDUCING BRAXTON HICKS AND ADVERSE EFFECTS OF NIFEDIPINE IN TREATMENT OF PREMATURE LABOR
Main Article Content
Abstract
Objectives: To describe the effectiveness of reducing braxton hicks and the adverse effects of nifedipine in treating premature labor.
Subjects and methods: a retrospective descriptive study on 220 pregnant women who came to the emergency department of Obstetrics and Gynecology, Vinh Long Provincial General Hospital, were diagnosed with premature labor from January 1st, 2021 to December 31st, 2021.
Results: The successful rate of prolongation of pregnancy ≥48 h in women with threatened preterm labor between 28 and 34 weeks treated with nifedipine was 70.5% (95% CI 66.6 – 74.0). The cumulative probability of successful treatment was more than 50% when the total treatment dose was at least 5 doses. The average length of gestational age was 21 days. The rate of pregnant women and fetuses with adverse effects of nifedipine during treatment was 6.4%, which often appeared transiently after the loading dose.
Conclusion: The success rate of prolonging pregnancy in women with threatened preterm birth with nifedipine was 70.5%. The incidence of adverse effects in pregnant women and fetuses of nifedipine was usually transient after the loading dose.
Article Details
Keywords
Nifedipine, premature labor, effectiveness, side effects.
References
Phác đồ điều trị sản phụ khoa: 140 - 147, 2019.
[2] American College of Obstetricians và
Gynecologists, Management of preterm labor:
Practice Bulletin no. 171. Obstet Gynecol,
128(4): e155-e164, 2016.26
B.D.M. Tri et al. / Vietnam Journal of Community
Medicine, Vol. 64, No. 5 (2023) 19-26
[3] U Ulmsten et al., Treatment of premature labor
with the calcium antagonist nifedipine. Archives
of gynecology, 229(1): 1-5, 1980.
[4] U Ulmsten, Treatment of normotensive and
hypertensive patients with preterm labor using
oral nifedipine, a calcium antagonist. Archives
of gynecology, 236(2): 69-72, 1984.
[5] Huỳnh Thị Mỹ Liên, Hiệu năng của Nifedipine
trong điều trị dọa sanh non, Đại học Y Dược
Thành phố Hồ Chí Minh, 2001.
[6] Purushottam BJ, Veena BD, Nifedipine versus
ritodrine for suppression of preterm labor and
analysis of side effects, The Journal of Obstetrics
and Gynecology of India, 61(5): 534-537, 2011.
[7] Phạm Tài, Hiệu quả của Nifedipine trong điều trị
dọa sinh non ở thai kỳ 28 - 34 tuần tại Bệnh viện
Hùng Vương, Đại học Y Dược Thành phố Hồ
Chí Minh, 2013.
[8] James EF II et al., A comparison of tocolysis with
nifedipine or ritodrine: analysis of efficacy and
maternal, fetal, and neonatal outcome, American
Journal of Obstetrics and Gynecology, 163(1):
105-111, 1990.
[9] Laura Means et al., Safety of Immediaterelease
nifedipine, Journal of cardiovascular
pharmacology, 68(5): 395-399, 2016.